A case of deep vein thrombosis in idiopathic nephrotic syndrome with resistance to activated protein C.
We report a case of deep vein thrombosis in a young man with idiopathic nephrotic syndrome and resistance to activated protein C. We postulate that patients with concurrent nephrotic syndrome and factor V may have an increased risk of thrombosis. Screening for factor V Leiden may be indicated in patients with idiopathic nephrotic syndrome.
Campisi
S
S
Department of Nephrology, General Hospital, Imperia, Italy.
Cavatorta
F
F
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage; D005165:Factor V / Q000235:genetics; D005455:Fluorescent Antibody Technique; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D009404:Nephrotic Syndrome / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D017354:Point Mutation; D011486:Protein C / Q000235:genetics*; D019851:Thrombophilia / Q000150:complications*; D013924:Thrombophlebitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D011486:Protein C; D014859:Warfarin; D005165:Factor V; D006493:Heparin; D008775:Methylprednisolone